Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients

PHASE1UnknownINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions
Mesothelioma
Interventions
BIOLOGICAL

MesoCancerVac

A leukapheresis is performed of which the monocytes are used for differentiation to DCs using specific cytokines. Pulsed autologous DCs (MesoCancerVac) are re-injected 3 times every two weeks. After the third injection with MesoCancerVac, revaccinations to boost the immune system are given after 3 and 6 months.

Trial Locations (1)

3015GD

RECRUITING

Erasmus MC, Dept. of Pulmonary Medicine, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER